Sen. Thomas R. Carper bought Revance Therapeutics (RVNC)
Sen. Thomas R. Carper (D-DE) · $1K–$15K · traded Oct 4, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Oct 4, 2023
- Disclosed
- Nov 2, 2023
- Days to disclose
- 29
- Asset type
- Stock
- As filed
- Revance Therapeutics, Inc. - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Nov 2, 2023$1K–$15K
Bought AdvisorShares Active Bear ETF HDGE
$1K–$15K · Traded Oct 20, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$1K–$15K
Sold (full) ProShares - Short QQQ PSQ
$1K–$15K · Traded Oct 20, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$50K–$100K
$50K–$100K · Traded Oct 19, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$15K–$50K
$15K–$50K · Traded Oct 19, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$50K–$100K
$50K–$100K · Traded Oct 19, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$15K–$50K
$15K–$50K · Traded Oct 18, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$50K–$100K
$50K–$100K · Traded Oct 18, 2023 · disclosed Nov 2, 2023 · Spouse
- Nov 2, 2023$1K–$15K
Sold (full) Structure Therapeutics GPCR
$1K–$15K · Traded Oct 4, 2023 · disclosed Nov 2, 2023 · Spouse
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.